Results 251 to 260 of about 72,745 (302)
Some of the next articles are maybe not open access.
Aspects of immunoglobulin replacement therapy
The Pediatric Infectious Disease Journal, 1990Immunoglobulin replacement therapy appears to benefit some patients who have IgG subclass deficiencies. Because some patients with subnormal trough concentrations of IgG subclasses remain well, because other patients who have borderline/low normal concentrations of an IgG subclass are abnormally infection-prone and helped by immunoglobulin therapy and ...
L J, Beard, A, Ferrante
openaire +2 more sources
Subcutaneous Immunoglobulin Replacement Therapy
Journal of Infusion Nursing, 2015Subcutaneous immunoglobulin (SCIg) infusions are an option for patients requiring immunoglobulin therapy. Nurses are uniquely positioned to advocate for patients and to teach them how to successfully manage their infusions. The purpose of this review is to describe SCIg therapy and to provide teaching instructions as well as creative tips to ensure ...
M Elizabeth M, Younger +5 more
openaire +2 more sources
Outcome of Immunoglobulin Replacement Therapy in Adults With Rhinosinusitis
The Laryngoscope, 2021ObjectiveTo evaluate the outcome of immunoglobulin (IG) replacement therapy in adults with rhinosinusitis and primary humoral immunodeficiency disorders (PID).Study DesignRetrospective cohort study.MethodsRetrospective chart review of adult (18 years and older) patients who were diagnosed with PID and had the diagnosis of recurrent acute rhinosinusitis
Chadi A. Makary +3 more
openaire +2 more sources
Immunoglobulin Replacement Therapy for Primary Immunodeficiency
Immunology and Allergy Clinics of North America, 2015Immunoglobulin replacement therapy has been standard treatment in patients with primary immunodeficiency diseases for the past 3 decades. The goal of therapy is to reduce serious bacterial infections in individuals with antibody function defects. Approximately one-third of patients receiving intravenous immunoglobulin treatment experience adverse ...
Panida, Sriaroon, Mark, Ballow
openaire +2 more sources
Immunoglobulin Replacement Therapy by Slow Subcutaneous Infusion
Annals of Internal Medicine, 1980Excerpt Alcohol fractionated immune serum globulin and fresh frozen plasma are the only generally available preparations used for replacement therapy in patients with antibody deficiency syndromes....
M, Berger, T R, Cupps, A S, Fauci
openaire +2 more sources
Nursing Guidelines for Administration of Immunoglobulin Replacement Therapy
Journal of Infusion Nursing, 2013Immunoglobulin (Ig) replacement therapy, given as regular infusions of pooled human Ig, is the recognized treatment of humoral immunodeficiencies characterized by hypogammaglobulinemia and impaired antibody responses. It is a safe, effective therapy when delivered by nurses who have been educated to oversee and/or provide these infusions.
Mary Elizabeth M, Younger +6 more
openaire +2 more sources
Intravenous and subcutaneous immunoglobulin G replacement therapy
Allergy and Asthma Proceedings, 2016Human polyclonal immunoglobulin G (IgG) for therapeutic use has been available for decades. This drug was developed for treatment of antibody deficiency (replacement therapy), although its use has expanded into many anti-inflammatory and immunomodulatory applications in recent years. This review focuses on IgG prescribing for replacement therapy.
openaire +2 more sources
Economic Assessment of Different Modalities of Immunoglobulin Replacement Therapy
Immunology and Allergy Clinics of North America, 2008The delivery (intravenous or subcutaneous), location (home or hospital), and other factors of immunoglobulin replacement therapy are examined for cost effectiveness. Cost-minimization studies from several countries are reviewed and analyzed. A Canadian cost-minimization study is performed.
Stephen K, Membe +5 more
openaire +2 more sources
Immunoglobulin Replacement Therapy
1988The basic concept that specific plasma substances can be important in host defence is a central theme in the historical development of immunology. As early as 1890, von Behring and Kitasato discovered that neutralizing antisera to tetanus and diphtheria toxins could be produced in animals by prior exposure to antigen and that the active principle was ...
openaire +1 more source
Immunoglobulin Replacement Therapy in Primary Antibody Deficiency Diseases – Maximizing Success
International Archives of Allergy and Immunology, 2005Antibody or humoral immunodeficiencies comprise the largest group of primary immunodeficiency diseases. Since the first description of patients with low gammaglobulin levels more than four decades ago, a great wealth of information has been accumulated.
Anne, Durandy +3 more
openaire +2 more sources